A business in context
KYMR research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-05-26 | Chadwick Jeremy G | S · Sale | Common Stock | 3730.0 | 78.36 |
| 2026-05-26 | Chadwick Jeremy G | S · Sale | Common Stock | 324.0 | 79.17 |
| 2026-05-26 | Chadwick Jeremy G | S · Sale | Common Stock | 3800.0 | 79.39 |
| 2026-05-26 | Chadwick Jeremy G | S · Sale | Common Stock | 551.0 | 80.71 |
| 2026-05-26 | Chadwick Jeremy G | S · Sale | Common Stock | 4500.0 | 80.02 |
| 2026-05-19 | Esposito Pamela | M · Exercise / conversion | Common Stock | 1000.0 | 31.2 |
| 2026-05-19 | Esposito Pamela | M · Exercise / conversion | Stock Option (Right to Buy) | 1000.0 | 0.0 |
| 2026-05-18 | Jacobs Bruce N. | M · Exercise / conversion | Common Stock | 15000.0 | 2.08 |
| 2026-05-18 | Jacobs Bruce N. | M · Exercise / conversion | Stock Option (Right to Buy) | 15000.0 | 0.0 |
| 2026-05-11 | Ridloff Elena | M · Exercise / conversion | Common Stock | 3000.0 | 31.2 |
| 2026-05-11 | Ridloff Elena | S · Sale | Common Stock | 3000.0 | 87.0 |
| 2026-05-11 | Ridloff Elena | M · Exercise / conversion | Stock Option (Right to Buy) | 3000.0 | 0.0 |
| 2026-04-29 | Mainolfi Nello | M · Exercise / conversion | Common Stock | 30000.0 | 2.08 |
| 2026-04-29 | Mainolfi Nello | S · Sale | Common Stock | 936.0 | 82.45 |
| 2026-04-29 | Mainolfi Nello | S · Sale | Common Stock | 17005.0 | 80.74 |
| 2026-04-29 | Mainolfi Nello | S · Sale | Common Stock | 12059.0 | 81.7 |
| 2026-04-29 | Mainolfi Nello | M · Exercise / conversion | Stock Option (Right to Buy) | 30000.0 | 0.0 |
| 2026-04-22 | Booth Bruce | M · Exercise / conversion | Common Stock | 5641.0 | 14.18 |
| 2026-04-22 | Booth Bruce | S · Sale | Common Stock | 88.0 | 90.08 |
| 2026-04-22 | Booth Bruce | S · Sale | Common Stock | 5900.0 | 89.96 |
| 2026-04-22 | Booth Bruce | S · Sale | Common Stock | 12.0 | 90.08 |
| 2026-04-22 | Booth Bruce | M · Exercise / conversion | Common Stock | 259.0 | 20.0 |
| 2026-04-22 | Booth Bruce | M · Exercise / conversion | Stock Option (Right to Buy) | 259.0 | 0.0 |
| 2026-04-22 | Booth Bruce | M · Exercise / conversion | Stock Option (Right to Buy) | 5641.0 | 0.0 |
| 2026-04-22 | Chadwick Jeremy G | S · Sale | Common Stock | 300.0 | 90.0 |
| 2026-04-22 | Chadwick Jeremy G | M · Exercise / conversion | Common Stock | 100.0 | 30.17 |
| 2026-04-22 | Chadwick Jeremy G | M · Exercise / conversion | Common Stock | 200.0 | 43.5 |
| 2026-04-22 | Chadwick Jeremy G | M · Exercise / conversion | Stock Option (Right to Buy) | 200.0 | 0.0 |
| 2026-04-22 | Chadwick Jeremy G | M · Exercise / conversion | Stock Option (Right to Buy) | 100.0 | 0.0 |
| 2026-04-15 | Booth Bruce | M · Exercise / conversion | Common Stock | 2200.0 | 14.18 |
| 2026-04-15 | Booth Bruce | S · Sale | Common Stock | 2200.0 | 89.95 |
| 2026-04-15 | Booth Bruce | S · Sale | Common Stock | 2750.0 | 90.1 |
| 2026-04-15 | Booth Bruce | S · Sale | Common Stock | 385.0 | 90.1 |
| 2026-04-15 | Booth Bruce | M · Exercise / conversion | Stock Option (Right to Buy) | 2200.0 | 0.0 |
| 2026-04-15 | Chadwick Jeremy G | S · Sale | Common Stock | 1300.0 | 90.0 |
| 2026-04-15 | Chadwick Jeremy G | M · Exercise / conversion | Common Stock | 1300.0 | 43.5 |
| 2026-04-15 | Chadwick Jeremy G | M · Exercise / conversion | Stock Option (Right to Buy) | 1300.0 | 0.0 |
| 2026-04-14 | Booth Bruce | M · Exercise / conversion | Common Stock | 4159.0 | 14.18 |
| 2026-04-14 | Booth Bruce | S · Sale | Common Stock | 4159.0 | 89.97 |
| 2026-04-14 | Booth Bruce | M · Exercise / conversion | Stock Option (Right to Buy) | 4159.0 | 0.0 |
| 2026-04-14 | Goodman Noah | S · Sale | Common Stock | 1347.0 | 90.0 |
| 2026-04-14 | Chadwick Jeremy G | M · Exercise / conversion | Common Stock | 4466.0 | 30.17 |
| 2026-04-14 | Chadwick Jeremy G | S · Sale | Common Stock | 5251.0 | 90.0 |
| 2026-04-14 | Chadwick Jeremy G | M · Exercise / conversion | Common Stock | 785.0 | 43.5 |
| 2026-04-14 | Chadwick Jeremy G | M · Exercise / conversion | Stock Option (Right to Buy) | 785.0 | 0.0 |
| 2026-04-14 | Chadwick Jeremy G | M · Exercise / conversion | Stock Option (Right to Buy) | 4466.0 | 0.0 |
| 2026-04-10 | Goodman Noah | S · Sale | Common Stock | 2000.0 | 87.35 |
| 2026-04-09 | Goodman Noah | S · Sale | Common Stock | 3094.0 | 86.62 |
| 2026-04-09 | Goodman Noah | M · Exercise / conversion | Common Stock | 2500.0 | 21.05 |
| 2026-04-09 | Goodman Noah | S · Sale | Common Stock | 2670.0 | 87.11 |
Identity & relationships
SEC issuer · 0001815442Kymera Therapeutics, Inc.
Search names and former names
View Wikidata identity and references ↗
- Kymera Therapeutics · alias · wikidata
- Kymera Therapeutics, Inc. · former SEC name · 2020-06-22 to 2026-09-04
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $47.07M | $50.11M |
| 2023-12-31 | $78.59M | $86.12M |
| 2022-12-31 | $46.83M | $53.42M |
| 2021-12-31 | $72.83M | $89.74M |
| 2020-12-31 | $34.03M | $43.91M |
| 2019-12-31 | $2.93M | $3.83M |